Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, Gantzer J, Thouvenin J, Baltzinger P, Bouarich R, Manriquez V, Zaidi S, Rao P, Msaouel P, Su X, Lang H, Tricard T, Lindner V, Surdez D, Kurtz JE, Bourdeaut F, Tannir NM, Davidson I, Malouf GG. Vokshi BH, et al. Among authors: msaouel p. Nat Commun. 2023 May 26;14(1):3034. doi: 10.1038/s41467-023-38472-y. Nat Commun. 2023. PMID: 37236926 Free PMC article.
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.
Tannir NM, Msaouel P, Ross JA, Devine CE, Chandramohan A, Gonzalez GMN, Wang X, Wang J, Corn PG, Lim ZD, Pruitt L, Karam JA, Wood CG, Zurita AJ. Tannir NM, et al. Among authors: msaouel p. Eur Urol Oncol. 2020 Oct;3(5):687-694. doi: 10.1016/j.euo.2019.06.004. Epub 2019 Jul 2. Eur Urol Oncol. 2020. PMID: 31272939 Free PMC article. Clinical Trial.
Medicine before and after David Cox.
Msaouel P, Jimenez-Fonseca P, Lim B, Carmona-Bayonas A, Agnelli G. Msaouel P, et al. Eur J Intern Med. 2022 Apr;98:1-3. doi: 10.1016/j.ejim.2022.02.022. Epub 2022 Feb 28. Eur J Intern Med. 2022. PMID: 35241350
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience.
Alhalabi O, Hasanov E, Wilson NR, Araujo J, Wang J, Campbell MT, Goswami S, Shah AY, Gao J, Msaouel P, Tannir NM. Alhalabi O, et al. Among authors: msaouel p. Int J Cancer. 2021 Jul 15;149(2):387-393. doi: 10.1002/ijc.33560. Epub 2021 Mar 24. Int J Cancer. 2021. PMID: 33739450 Free article.
The evolving treatment landscape of advanced urothelial carcinoma.
Andreev-Drakhlin AY, Egoryan G, Shah AY, Msaouel P, Alhalabi O, Gao J. Andreev-Drakhlin AY, et al. Among authors: msaouel p. Curr Opin Oncol. 2021 May 1;33(3):221-230. doi: 10.1097/CCO.0000000000000722. Curr Opin Oncol. 2021. PMID: 33818541 Review.
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. De B, et al. Among authors: msaouel p. BJU Int. 2022 May;129(5):610-620. doi: 10.1111/bju.15541. Epub 2021 Jul 23. BJU Int. 2022. PMID: 34228889 Free PMC article.
174 results